纳美信（上海）生物科技有限公司 Reviews

Company Overview

Nature: 民营公司 Size: 50-99人 Founded: 5年
Industry: 制药/生物工程
Full name: 纳美信（上海）生物科技有限公司。

Development Stage

Stage: A轮。
Honors: 科技型中小企业市科技型中小企业 According to algorithm

About the Company

纳美信生物成立于2015年，专注于前沿生物药物和下一代疫苗的研发，公司以核心平台技术作为研发基础，包括核酸序列设计与合成平台、递送系统平台、基于AI的靶序列优化平台等。

Expand

Information is aggregated from the web and may not be exact. For reference only.

Information incorrect? Claim this company to edit

纳美信 Financing History (1 rounds)

Manage

A轮

Capital Market Favor

Latest Financing Round

Date: ?
Amount: 融资金额未公开
Investor: 国生资本，恩然创投

纳美信 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

纳美信 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Footprints / Contact / Network (latest company updates)

Manage

Company / Job Addresses

中国（上海）自由贸易试验区临港新片区环湖西二路888号C楼 

Nearby Companies

Business Registration

Provided by

Operating Status: 开业

Registered Capital: 1,976万(元)

Legal Representative: 邓明

Date Established:

Credit Code: 91310000MA1H3T8P5Q

Registered Address: 中国（上海）自由贸易试验区张江路368号22幢104室

Talent Demand Trend Analysis More

生物科技/生物工程 +50%

生物科技 +54%

医药 +33%

核苷酸 +64%

制药/药业 +21%

疫苗技术 +74%

生物制品 +63%

人用疫苗 +39%

生物医药 +74%

医药工业 +129%

生物制药 +76%

People who follow 纳美信 also follow

纳美信 Competitors (Similar Companies)

Follow in Bulk Copy Company Names

杭州湃肽生化科技有限公司

多肽 CRO 多肽原料药药物研发外包

苏州信诺维医药科技股份有限公司

“生物医药研发商”

华海天衡（上海）药物研究股份有限公司

抗体药物研发创新药研发

中 中文版 View this page in Chinese ›

Discover Great Companies, Discover Great Clients

上海公司排名  上海“浦东新区”公司排名  上海“生物科技/生物工程”公司排名  上海“生物科技”公司排名  上海“医药”公司排名  上海“核苷酸”公司排名  上海“制药/药业”公司排名  附近的公司 

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

纳美信